SCHEMBL301495

SCHEMBL301495

O=C1CC(C(=O)O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28490005 0.97 — —
Benzene SCHEMBL27796799 0.94 AKR1C3 (0.43) —
SCHEMBL2083101 0.88 ABAT (0.48) —
SCHEMBL2079668 0.88 ABAT (0.48) —
SCHEMBL1839380 0.88 MAPT (0.44) —
SCHEMBL6295811 0.79 CYP2C19 (0.39) —
SCHEMBL29883233 0.78 — —
SCHEMBL51838 0.78 — —
SCHEMBL1666449 0.78 — —
SCHEMBL3295484 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1532 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735444-A1 BENZYL (3-(METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4YL)AMINO)CYCLOBUTYL) CARBAMATE OR A SALT THEREOF, METHOD FOR THE PREPARATION THEREOF, AND USE THEREOF IN THE SYNTHESIS OF ABROCITINIB Moehs Ibérica, S.L. (ES) 2026-05-06 — — EP claimed
EP-4626886-A1 JAK INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS OnQuality Pharmaceuticals China Ltd. (CN) 2025-10-08 — — EP claimed
CN-119490397-A Bicyclo [1.1.0] butanone compound and synthesis method thereof 浙江工业大学 2025-02-21 — — CN claimed
CN-119462360-A Synthesis method of 3-oxo-1-cyclobutanecarboxylic acid 中昊(大连)化工研究设计院有限公司 2025-02-18 — — CN claimed
WO-2025003177-A1 BENZYL (3-(METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4YL)AMINO)CYCLOBUTYL) CARBAMATE OR A SALT THEREOF, METHOD FOR THE PREPARATION THEREOF, AND USE THEREOF IN THE SYNTHESIS OF ABROCITINIB MOEHS IBERICA, S.L. (ES) 2025-01-02 — — WO claimed
CN-118561689-B Preparation method of 3-oxo-cyclobutanecarboxylic acid ester compound 中节能万润股份有限公司 2024-11-22 — — CN claimed
CN-118876522-A Laminated bulletproof glass and preparation process thereof 侯凯莉 2024-11-01 — — CN claimed
CN-118530108-B Preparation method of 3-oxo-cyclobutanecarboxylic acid 中节能万润股份有限公司 2024-10-01 — — CN claimed
CN-118561689-A Preparation method of 3-oxo-cyclobutanecarboxylic acid ester compound 中节能万润股份有限公司 2024-08-30 — — CN claimed
CN-118530108-A Preparation method of 3-oxo-cyclobutanecarboxylic acid 中节能万润股份有限公司 2024-08-23 — — CN claimed
CN-103232340-A Synthesis method of 3-oxocyclobutanecarboxylic acid LANZHOU WOJIN ENVIRONMENT PROT SCIENCE AND TECHNOLOGY CO LTD 2013-08-07 — — CN claimed
CN-101555205-B Preparing method of 3-oxo-1-cyclobutane-carboxylic acid ZHEJIANG GENEBEST PHARMACEUTICAL CO LTD 2011-11-23 — — CN claimed
CN-101555205-A Preparing method of 3-oxo-1-cyclobutane-carboxylic acid ZHEJIANG GENEBEST PHARMACEUTIC (CN) 2009-10-14 — — CN claimed
EP-1987036-A1 HETERO-BYCYCLIC ANTIVIRAL COMPOUNDS F.HOFFMANN-LA ROCHE AG (CH) 2008-11-05 — — EP claimed
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 — — EP claimed
WO-2007093520-A1 HETERO-BYCYCLIC ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-23 — — WO claimed
US-20070191335-A1 4-{2-[5-(4,6-Dimethyl-pyrimidine-5-carbonyl)-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl]-ethyl}-4-phenyl-piperidine-1-carboxylic acid tert-butyl ester,chemokine receptor antagonist; human immunodeficiency virus (HIV) infection, AIDS or ARC, antiinflammatory agent, autoimmune diseases, graft v. host disease ROCHE PALO ALTO LLC 2007-08-16 — — US claimed
CN-101001860-A Heterocyclic antiviral compounds ROCHE PALO ALTO LLC (CH) 2007-07-18 — — CN claimed
EP-1761542-A2 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS F.HOFFMANN-LA ROCHE AG (CH) 2007-03-14 — — EP claimed
WO-2005121145-A2 OCTAHYDRO-PYRROLO[3,4-C] DERIVATIVES AND THEIR USE AS ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2005-12-22 — — WO claimed
Send feedback